The companies said that their vaccine was safe and effective in that age group, and that they would submit a formal request in the coming weeks to U.S. regulators to allow a pediatric dose.The companies said that their vaccine was safe and effective in that age group, and that they would submit a formal request in the coming weeks to U.S. regulators to allow a pediatric dose.Children and Childhood, Vaccination and Immunization, Clinical Trials, Coronavirus (2019-nCoV), Pfizer Inc, BioNTech SE, Food and Drug AdministrationRead More
